High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
about
Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinomaForkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinomaTumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionIdentification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1.FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.FOXC1: an emerging marker and therapeutic target for cancer.Forkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcomaThe forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.Research progress on the forkhead box C1.Silencing FOXC1 inhibits growth and migration of human oral squamous cell carcinoma cellsLong noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1
P2860
Q26739910-96EDD80E-A236-4BA9-8F17-BF78F0A2D336Q28268527-E2B479D0-E7A6-4AEB-8E77-31AD770BCE1CQ33588186-E20CC5A5-8B66-4EA4-9C18-B190BD3B10ADQ33814357-539DEC60-34E2-4E5D-9C37-FA46F3038A2EQ33898799-EA9035A4-0861-4900-8F24-6E41158D8F93Q34543873-26B8E3F9-6867-4939-8266-3E2884A6D0CDQ34657038-E9C0E10F-6FB5-4D08-8D9E-8C26824B5BDBQ35713143-9A28DCAB-5070-400C-AFCE-E2BD771E52E3Q37708952-506CF657-64D8-4623-AABB-2542078D479FQ38699560-C5D85E26-4161-45BD-911A-579412951AC0Q38989090-9F75BD93-9B9B-48A3-91B6-3C1DDADFEB13Q39014939-AA118517-9BF0-4EA2-AECB-D3B17A654587Q39176111-D5392517-ABA9-4E64-857C-CAC1408CE061Q41623598-442E79D6-F28F-4AEA-BE6B-B8F5078CE51FQ43914090-5EB961E3-7CE3-4AD3-BC49-A41EE0C810AEQ49624286-A2E7AFC5-DA83-48ED-B1E1-2C1E5BC1B627Q51525514-D16C7BC4-D94C-4501-A70A-BAC1FC2CBA43Q53542144-B8B5315F-3F57-477B-9626-7280DFAFDD99Q53701147-699B660A-7004-4593-A12E-ECD8C5E2DED2Q58733344-49C8326A-4F3D-4EB3-BCB1-97264DF75878Q58746865-5B5CD346-D7DC-417F-B49A-3246FBB063BE
P2860
High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@en
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@nl
type
label
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@en
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@nl
prefLabel
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@en
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
High level of FOXC1 expression ...... creatic ductal adenocarcinoma.
@en
P2093
Chao-Ying Liu
Jun-Ying Xu
Run-Jie Wang
P2860
P2888
P304
P356
10.1007/S13277-012-0617-7
P577
2012-12-16T00:00:00Z